HZNP — Horizon Therapeutics Share News
0.000.00%
HealthcareBalancedLarge Cap
- $26.63bn
- $26.72bn
- $3.63bn
Horizon Therapeutics slumps as US FTC sues to block Amgen's $27.8 bln deal
FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics -statement
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
Brief: FTC Commissioners Have Not Yet Met On Amgen-Horizon Deal - CNBC Citing Sources
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking Therapeutics, Newell Brands, Seagen
U.S. STOCKS ON THE MOVE-Home Depot, Netflix, Coinbase
FTC scrutiny to block Amgen-Horizon deal drags Seagen down
Refinitiv Newscasts - U.S. Morning Call: House Speaker McCarthy sees little sign of progress on debt-ceiling talks
Deals of the day-Mergers and acquisitions
Horizon Therapeutics slumps on report U.S. FTC to block Amgen's $27.8 bln deal
FTC to block Amgen's deal to acquire Horizon Therapeutics - source (updated)
Brief: FTC Is Expected To File A Complaint As Early As Tuesday To Block Amgen's Deal To Buy Horizon Therapeutics- Source
FTC to block Amgen's deal to acquire Horizon - source
FTC to block Amgen's deal to buy Horizon - Bloomberg News
Brief: FTC Will Sue To Block Amgen’s Deal To Buy Horizon Therapeutics - Bloomberg News
Horizon Therapeutics PLC reports results for the quarter ended in March - Earnings Summary
Brief: Horizon Therapeutics Posts Q1 EPS of USD 0.23